Albert Kildani | VP, IR & Corporate Communications |
Laurie Stelzer | SVP & CFO |
Helen Torley | President, CEO & Director |
Dimitrios Chondros | Chief Medical Officer & SVP |
James Birchenough | Wells Fargo Securities |
Jason Butler | JMP Securities |
Daniel Wolle | JPMorgan Chase & Co. |
Arlinda Lee | Canaccord Genuity |
Joel Beatty | Citigroup |
Pete Stavropoulos | Cantor Fitzgerald & Co. |
Joseph Catanzaro | Piper Jaffray Companies |
Good afternoon, everyone. I would now like to turn the conference over to Al Kildani, Vice President of Investor Relations and Corporate Communications for Halozyme Therapeutics. Mr. Kildani, please begin.
Good afternoon, and welcome to our First Quarter 2019 Financial Results Conference Call.